Κλαύδιος Γαληνός
Δωρεάν εγγραφή Αποκτήσετε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr για έναν μήνα
Έλεγχος συγχορήγησης Ελέγξτε την αγωγή σας για αντενδείξεις και αλληλεπιδράσεις μεταξύ των φαρμάκων
Μητρότητα και φάρμακα Ενημερωθείτε για την ασφάλεια χορήγησης ενός φαρμάκου κατά τη διάρκεια της εγκυμοσύνης ή του θηλασμού
Συνδρομές Μάθετε περισσότερα για τα οφέλη και τις επιπλέον παροχές των συνδρομητικών προγραμμάτων
Ενδείξεις και αγωγές Βρείτε θεραπευτικές ενδείξεις και αγωγές για νόσους, συμπτώματα και ιατρικές πράξεις
Γνωρίζατε ότι... Μοιραζόμαστε μαζί σας γεγονότα της πορείας του Galinos.gr από το 2011 μέχρι σήμερα

FENISTIL COLD SORE Cream (2016)

Αναφορές

Βιβλιογραφική αναφορά

Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή

Περιεχόμενα

Name of the medicinal product

Fenistil Cold Sore Cream.

Qualitative and quantitative composition

Each gram of the cream contains: 10 mg penciclovir. Excipients with known effect: cetostearyl alcohol, propylene glycol. For a full list of excipients, see section 6.1.

Pharmaceutical form

Cream. Smooth white cream of homogeneous appearance.

Therapeutic indications

Fenistil Cold Sore Cream is indicated for the treatment of herpes simplex virus infections of the lips and face (herpes labialis) in adults (including older people) and children over 12 years of age. ...

Posology and method of administration

Adults (including older people) and children over 12 years of age Fenistil Cold Sore Cream should be applied at approximately two hourly intervals during waking hours, (approximately 8 times a day). Treatment ...

Contraindications

Hypersensitivity to penciclovir, famciclovir or to any of the excipients listed in section 6.1.

Special warnings and precautions for use

The cream should only be used on cold sores on the lips and around the mouth. It is not recommended for application to mucous membranes (e.g. in the eyes, mouth, or nose or on the genitals). Particular ...

Interaction with other medicinal products and other forms of interaction

Clinical trial experience has not identified any interactions resulting from concomitant administration of topical or systemic drugs with Fenistil Cold Sore Cream.

Pregnancy and lactation

Pregnancy There is unlikely to be any cause for concern regarding adverse effects when the cream is used in pregnant women as systemic absorption of penciclovir following topical administration of Fenistil ...

Effects on ability to drive and use machines

Fenistil Cold Sore Cream has no influence on the ability to drive and use machines.

Undesirable effects

Summary of the safety profile Fenistil Cold Sore Cream has been well-tolerated in human studies. Clinical trial experience has shown that there was no difference between Fenistil Cold Sore Cream and placebo ...

Overdose

No untoward effects would be expected even if the entire contents of a container of Fenistil Cold Sore Cream were ingested orally; penciclovir is poorly absorbed following oral administration. However, ...

Pharmacodynamic properties

Pharmacotherapeutic group: Topical antiviral agent ATC code: D06BB06 Mechanism of action Penciclovir has demonstrated in vivo and in vitro activity against herpes simplex viruses (types 1 and 2) and varicella ...

Pharmacokinetic properties

General characteristics Following application of Fenistil Cold Sore Cream in a human volunteer study at a daily dose of 180mg penciclovir (approximately 67 times the proposed daily clinical dose), to occluded ...

Preclinical safety data

General toxicology Topical application of 5% Fenistil Cold Sore Cream for 4 weeks to rats and rabbits was well tolerated. There was no evidence of contact sensitisation in guinea pigs. A full programme ...

List of excipients

White soft paraffin Liquid paraffin Cetostearyl alcohol Propylene glycol Cetomacrogol 1000 Purified water

Incompatibilities

Not applicable.

Shelf life

2g aluminium tubes 3 years.

Special precautions for storage

Store at temperatures not exceeding 30°C. Do not freeze.

Nature and contents of container

2g aluminium tube.

Special precautions for disposal and other handling

Any unused product or waste material should be disposed of in accordance with local requirements.

Marketing authorization holder

Omega Pharma Ltd., 1st Floor, 32 Vauxhall Bridge Road, LONDON, SW1V 2SA, United Kingdom

Marketing authorization number(s)

PL 02855/0306

Date of first authorization / renewal of the authorization

23/08/2006

Date of revision of the text

22/02/2016

Πηγαίο έγγραφο

Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση:

Μπορείτε να υποστηρίξετε τον Γαληνό στην αποστολή του να παρέχει δωρεάν έγκυρη πληροφόρηση για κάθε φάρμακο απενεργοποιώντας το Ad Blocker για αυτόν τον ιστότοπο.